Insider Trading activities of Boston Scientific Corp insiders. , Part 4

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Boston Scientific Corp since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Boston Scientific Corp since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Boston Scientific Corp since 2005. The reporting company's ticker symbol is BSX. The reporting company's CIK number is 885725.
The total value of stock buying since 2005 is $23,762,101.
The total value of stock sales since 2005 is $881,921,170.
The total value of stock option exercises since 2005 is $81,857,292.



Table 2. Detailed insider stock purchases, sales, and option exercises of Boston Scientific Corp insiders (BSX) , Part 4
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2014-11-10 Lance Jean Fitterer (SVP & Chief Compliance Officer) Sale 15,000 13.40 201,000
2014-11-10 Ludwig Edward J (Director) Buy 10,000 13.38 133,840
2014-11-05 Sununu John E (Director) Sale 8,997 13.38 120,379
2014-11-03 Mario Ernest (Director) Sale 10,000 13.30 133,000
2014-11-01 Mahoney Michael F (President & CEO) Option Ex 341,669 .00 0
2014-10-08 Mario Ernest (Director) Sale 10,000 12.06 120,600
2014-09-02 Mario Ernest (Director) Sale 10,000 12.60 125,990
2014-08-15 Phalen Michael P. (EVP & President, MedSurg) Sale 11,471 12.58 144,305
2014-08-15 Phalen Michael P. (EVP & President, MedSurg) Option Ex 11,471 7.86 90,104
2014-08-01 Mario Ernest (Director) Sale 10,000 12.58 125,820
2014-07-30 Pierce David A (SVP and President, Endoscopy) Sale 157 12.96 2,035
2014-07-28 Mirviss Jeffrey B. (SVP&Pres, Periph Intervent) Option Ex 3,364 .00 0
2014-07-28 Pierce David A (SVP and President, Endoscopy) Option Ex 234 .00 0
2014-07-15 Phalen Michael P. (EVP & President, MedSurg) Sale 67,500 13.04 879,997
2014-07-15 Phalen Michael P. (EVP & President, MedSurg) Option Ex 67,500 7.86 530,212
2014-07-02 Prange Karen (SVP&Pres, Uro & Women's Health) Option Ex 25,862 .00 0
2014-07-01 Mario Ernest (Director) Sale 10,000 12.95 129,469
2014-06-16 Phalen Michael P. (EVP & President, MedSurg) Sale 13,500 13.02 175,824
2014-06-16 Phalen Michael P. (EVP & President, MedSurg) Option Ex 13,500 7.86 106,042
2014-06-02 Mario Ernest (Director) Sale 10,000 12.88 128,790
2014-05-15 Phalen Michael P. (EVP & President, MedSurg) Sale 13,500 12.76 172,206
2014-05-15 Phalen Michael P. (EVP & President, MedSurg) Option Ex 13,500 7.86 106,042
2014-05-01 Mario Ernest (Director) Sale 10,000 12.58 125,840
2014-04-15 Phalen Michael P. (EVP & President, MedSurg) Sale 13,500 13.25 178,861
2014-04-15 Phalen Michael P. (EVP & President, MedSurg) Option Ex 13,500 7.86 106,042
2014-04-01 Mario Ernest (Director) Sale 10,000 13.55 135,530
2014-03-17 Phalen Michael P. (EVP & President, MedSurg) Sale 13,500 13.04 176,107
2014-03-17 Phalen Michael P. (EVP & President, MedSurg) Option Ex 13,500 7.86 106,042
2014-03-06 Pierce David A (SVP and President, Endoscopy) Sale 5,316 13.44 71,457
2014-03-06 Phalen Michael P. (EVP & President, MedSurg) Sale 7,281 13.44 97,871
2014-03-03 Pierce David A (SVP and President, Endoscopy) Sale 4,829 12.97 62,632
2014-03-03 Phalen Michael P. (EVP & President, MedSurg) Sale 3,362 12.97 43,605
2014-03-03 Mario Ernest (Director) Sale 10,000 12.98 129,760
2014-02-28 Brennan Daniel J. (EVP and CFO) Option Ex 5,500 .00 0
2014-02-28 Mirviss Jeffrey B. (SVP&Pres, Periph Intervent) Option Ex 7,911 .00 0
2014-02-28 Prange Karen (SVP&Pres, Uro & Women's Health) Option Ex 3,721 .00 0
2014-02-28 Ballinger Kevin J. (SVP & Pres, Interven Cardio) Option Ex 11,338 .00 0
2014-02-28 Carruthers Wendy (SVP, Human Resources) Option Ex 6,515 .00 0
2014-02-28 Bose Supratim (EVP & President, Asia-Pacific) Option Ex 6,765 .00 0
2014-02-28 Mahoney Michael F (President & CEO) Option Ex 50,744 .00 0
2014-02-28 Pierce David A (SVP and President, Endoscopy) Option Ex 7,889 .00 0
2014-02-28 Nanavaty Maulik (SVP & Pres, Neuromodulation) Option Ex 5,652 .00 0
2014-02-28 Dawkins Keith D (EVP, Global Chief Med. Off.) Option Ex 9,625 .00 0
2014-02-28 Fitzgerald Joseph Michael (EVP & President, CRM) Option Ex 9,581 .00 0
2014-02-28 Phalen Michael P. (EVP & President, MedSurg) Option Ex 13,792 .00 0
2014-02-28 Lance Jean Fitterer (SVP & Chief Compliance Officer) Sale 10,000 13.20 131,980
2014-02-28 Lance Jean Fitterer (SVP & Chief Compliance Officer) Option Ex 7,572 .00 0
2014-02-28 Onuscheck John Michael (SVP & President, Europe) Option Ex 9,297 .00 0
2014-02-28 Pratt Timothy A. (EVP, GC & Chief Admin Officer) Option Ex 18,932 .00 0
2014-02-28 Pucel Kenneth (EVP, Glob Ops, Qual & Tech) Option Ex 19,947 .00 0
2014-02-27 Brennan Daniel J. (EVP and CFO) Option Ex 4,976 .00 0
2014-02-27 Mirviss Jeffrey B. (SVP&Pres, Periph Intervent) Option Ex 2,388 .00 0
2014-02-27 Ballinger Kevin J. (SVP & Pres, Interven Cardio) Option Ex 3,185 .00 0
2014-02-27 Carruthers Wendy (SVP, Human Resources) Option Ex 4,618 .00 0
2014-02-27 Bose Supratim (EVP & President, Asia-Pacific) Option Ex 3,185 .00 0
2014-02-27 Mahoney Michael F (President & CEO) Option Ex 57,325 .00 0
2014-02-27 Pierce David A (SVP and President, Endoscopy) Sale 2,057 13.29 27,343
2014-02-27 Pierce David A (SVP and President, Endoscopy) Option Ex 7,166 .00 0
2014-02-27 Nanavaty Maulik (SVP & Pres, Neuromodulation) Option Ex 6,369 .00 0
2014-02-27 Dawkins Keith D (EVP, Global Chief Med. Off.) Option Ex 8,758 .00 0
2014-02-27 Fitzgerald Joseph Michael (EVP & President, CRM) Option Ex 9,952 .00 0
2014-02-27 Phalen Michael P. (EVP & President, MedSurg) Sale 3,166 13.29 42,085
2014-02-27 Phalen Michael P. (EVP & President, MedSurg) Option Ex 10,350 .00 0
2014-02-27 Lance Jean Fitterer (SVP & Chief Compliance Officer) Option Ex 7,962 .00 0
2014-02-27 Onuscheck John Michael (SVP & President, Europe) Option Ex 7,962 .00 0
2014-02-27 Pratt Timothy A. (EVP, GC & Chief Admin Officer) Option Ex 13,535 .00 0
2014-02-27 Pucel Kenneth (EVP, Glob Ops, Qual & Tech) Option Ex 13,535 .00 0
2014-02-24 Brennan Daniel J. (EVP and CFO) Option Ex 3,612 .00 0
2014-02-24 Mirviss Jeffrey B. (SVP&Pres, Periph Intervent) Option Ex 3,012 .00 0
2014-02-24 Ballinger Kevin J. (SVP & Pres, Interven Cardio) Option Ex 3,145 .00 0
2014-02-24 Carruthers Wendy (SVP, Human Resources) Option Ex 3,012 .00 0
2014-02-24 Pierce David A (SVP and President, Endoscopy) Option Ex 3,012 .00 0
2014-02-24 Nanavaty Maulik (SVP & Pres, Neuromodulation) Option Ex 2,106 .00 0
2014-02-24 Dawkins Keith D (EVP, Global Chief Med. Off.) Option Ex 2,408 .00 0
2014-02-24 Fitzgerald Joseph Michael (EVP & President, CRM) Option Ex 1,323 .00 0
2014-02-24 Phalen Michael P. (EVP & President, MedSurg) Option Ex 4,698 .00 0
2014-02-24 Lance Jean Fitterer (SVP & Chief Compliance Officer) Option Ex 3,012 .00 0
2014-02-24 Pratt Timothy A. (EVP, GC & Chief Admin Officer) Option Ex 3,012 .00 0
2014-02-24 Pucel Kenneth (EVP, Glob Ops, Qual & Tech) Option Ex 3,012 .00 0
2014-02-21 Mirviss Jeffrey B. (SVP&Pres, Periph Intervent) Sale 8,000 13.19 105,528
2014-02-21 Ballinger Kevin J. (SVP & Pres, Interven Cardio) Sale 30,588 13.19 403,516
2014-02-21 Pierce David A (SVP and President, Endoscopy) Sale 3,199 13.21 42,274
2014-02-21 Phalen Michael P. (EVP & President, MedSurg) Sale 3,222 13.21 42,578
2014-02-19 Pucel Kenneth (EVP, Glob Ops, Qual & Tech) Sale 78,000 13.32 1,038,804
2014-02-18 Phalen Michael P. (EVP & President, MedSurg) Sale 13,500 13.30 179,550
2014-02-18 Phalen Michael P. (EVP & President, MedSurg) Option Ex 13,500 7.86 106,042
2014-02-16 Brennan Daniel J. (EVP and CFO) Option Ex 4,487 .00 0
2014-02-16 Mirviss Jeffrey B. (SVP&Pres, Periph Intervent) Option Ex 11,471 .00 0
2014-02-16 Ballinger Kevin J. (SVP & Pres, Interven Cardio) Option Ex 11,471 .00 0
2014-02-16 Carruthers Wendy (SVP, Human Resources) Option Ex 4,359 .00 0
2014-02-16 Pierce David A (SVP and President, Endoscopy) Option Ex 5,121 .00 0
2014-02-16 Nanavaty Maulik (SVP & Pres, Neuromodulation) Option Ex 2,115 .00 0
2014-02-16 Dawkins Keith D (EVP, Global Chief Med. Off.) Option Ex 3,373 .00 0
2014-02-16 Fitzgerald Joseph Michael (SVP & President, CRM) Option Ex 4,723 .00 0
2014-02-16 Phalen Michael P. (EVP & President, MedSurg) Option Ex 4,723 .00 0
2014-02-16 Lance Jean Fitterer (SVP & Chief Compliance Officer) Option Ex 4,588 .00 0
2014-02-16 Onuscheck John Michael (SVP & President, Europe) Option Ex 5,060 .00 0
2014-02-16 Pratt Timothy A. (EVP, GC & Chief Admin Officer) Option Ex 28,434 .00 0
2014-02-16 Pucel Kenneth (EVP, Glob Ops, Qual & Tech) Option Ex 6,747 .00 0
2014-02-14 Sununu John E (Director) Sale 29,561 13.17 389,318
2014-02-13 Johnson Kristina M (Director) Sale 18,000 13.01 234,108
2014-02-06 Mario Ernest (Director) Sale 17,104 12.80 218,931
2014-02-03 Mario Ernest (Director) Sale 10,000 13.19 131,880
2014-01-15 Phalen Michael P. (EVP & President, MedSurg) Sale 13,500 13.19 178,105
2014-01-15 Phalen Michael P. (EVP & President, MedSurg) Option Ex 13,500 7.86 106,042
2014-01-06 Mario Ernest (Director) Sale 10,000 12.50 125,000
2014-01-03 Bose Supratim (EVP & President, Asia-Pacific) Option Ex 14,925 .00 0
2013-12-26 Mario Ernest (Director) Sale 10,000 12.06 120,600
2013-11-27 Capello Jeffrey D (EVP & Chief Financial Officer) Sale 108,595 11.70 1,270,561
2013-11-26 Capello Jeffrey D (EVP & Chief Financial Officer) Sale 85,106 11.82 1,005,697
2013-11-26 Capello Jeffrey D (EVP & Chief Financial Officer) Option Ex 46,701 6.59 307,993
2013-11-25 Ballinger Kevin J. (SVP & Pres, Interven Cardio) Sale 33,334 12.05 401,674
2013-11-25 Capello Jeffrey D (EVP & Chief Financial Officer) Sale 242,504 12.02 2,915,140
2013-11-25 Capello Jeffrey D (EVP & Chief Financial Officer) Option Ex 242,504 7.39 1,792,104
2013-11-22 Capello Jeffrey D (EVP & Chief Financial Officer) Sale 150,000 12.02 1,803,150
2013-11-22 Capello Jeffrey D (EVP & Chief Financial Officer) Option Ex 150,000 7.82 1,173,000
2013-11-21 Dawkins Keith D (EVP, Global Chief Med. Off.) Sale 138,850 12.00 1,666,338
2013-11-21 Dawkins Keith D (EVP, Global Chief Med. Off.) Option Ex 138,850 7.62 1,058,453
2013-11-19 Pratt Timothy A. (EVP, GC & Chief Admin Officer) Sale 20,132 11.94 240,376
2013-11-11 Mirviss Jeffrey B. (SVP&Pres, Periph Intervent) Sale 6,000 12.02 72,126
2013-11-08 Mirviss Jeffrey B. (SVP&Pres, Periph Intervent) Sale 20,000 11.87 237,399
2013-11-08 Mario Ernest (Director) Sale 135,645 11.73 1,591,387
2013-11-01 Mahoney Michael F (President & CEO) Option Ex 341,669 .00 0
2013-11-01 Fitzgerald Joseph Michael (SVP & President, CRM) Sale 9,236 11.69 107,978
2013-10-28 Ballinger Kevin J. (SVP & Pres, Interven Cardio) Option Ex 2,594 .00 0
2013-08-29 Capello Jeffrey D (EVP & Chief Financial Officer) Sale 525,000 10.70 5,614,875
2013-08-29 Capello Jeffrey D (EVP & Chief Financial Officer) Option Ex 475,000 7.41 3,519,750
2013-08-16 Fitzgerald Joseph Michael (SVP & President, CRM) Sale 9,202 11.02 101,424
2013-08-14 Ballinger Kevin J. (SVP & Pres, Interven Cardio) Sale 38,171 11.28 430,645
2013-07-29 Fitzgerald Joseph Michael (SVP & President, CRM) Option Ex 6,665 .00 0
2013-07-29 Onuscheck John Michael (SVP & President, EMEA) Option Ex 4,165 .00 0
2013-07-28 Mirviss Jeffrey B. (SVP&Pres, Periph Intervent) Option Ex 3,364 .00 0
2013-07-28 Pierce David A (SVP and President, Endoscopy) Option Ex 234 .00 0
2013-07-02 Prange Karen (SVP&Pres, Uro & Women's Health) Option Ex 25,862 .00 0
2013-06-16 Capello Jeffrey D (EVP & Chief Financial Officer) Option Ex 14,665 .00 0
2013-05-31 Mirviss Jeffrey B. (SVP&Pres, Periph Intervent) Sale 10,941 9.37 102,495
2013-05-30 Carruthers Wendy (SVP, Human Resources) Sale 25,001 9.15 228,884
2013-05-29 Connors Nelda J (Director) Sale 24,116 9.17 221,143
2013-05-12 Capello Jeffrey D (EVP & Chief Financial Officer) Option Ex 7,235 .00 0
2013-05-06 Mario Ernest (Director) Buy 30,000 7.76 232,800
2013-05-01 Pratt Timothy A. (EVP, GC & Chief Admin Officer) Option Ex 14,746 .00 0
2013-02-28 Mirviss Jeffrey B. (SVP&Pres, Periph Intervent) Option Ex 4,190 .00 0
2013-02-28 Ballinger Kevin J. (SVP & Pres, Interven Cardio) Option Ex 5,586 .00 0
2013-02-28 Carruthers Wendy (SVP, Human Resources) Option Ex 2,793 .00 0
2013-02-28 Pierce David A (SVP and President, Endoscopy) Option Ex 3,491 .00 0
2013-02-28 Nanavaty Maulik (SVP & Pres, Neuromodulation) Option Ex 2,269 .00 0
2013-02-28 Dawkins Keith D (EVP, Global Chief Med. Off.) Option Ex 4,888 .00 0
2013-02-28 Fitzgerald Joseph Michael (SVP & President, CRM) Option Ex 3,491 .00 0
2013-02-28 Phalen Michael P. (EVP & President, MedSurg) Option Ex 8,379 .00 0
2013-02-28 Lance Jean Fitterer (SVP & Chief Compliance Officer) Option Ex 4,190 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises of BSX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Boston Scientific Corp (symbol BSX, CIK number 885725) see the Securities and Exchange Commission (SEC) website.